Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis—a case series
Laura Bucci; Melanie Hagen; Sebastian Böltz; Carlo Tur; Danae-Mona Nöthling; Tobias Dashi; Janina Auth; Tobias Rothe; Andreas Wirsching; Jochen Wacker; Futoshi Iwata; Andrea Zoli; Anna-Maria Liphardt; Stefano Alivernini; Luis Munoz; Verena Schönau; Jürgen Rech; Armin Atzinger; Maria-Antonietta D’Agostino; Aline Bozec; Markus Eckstein; Maria Gabriella Raimondo; Georg Schett; Ricardo Grieshaber-BouyerShow moreShow less
Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Department of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCSS, Catholic University of Sacred Heart, Roma, Italy; Department of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Department of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Department of Medicine, Karolinska Institutet, Stockholm, SwedenShow moreShow less
EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis
Stéphane Hilliquin; Olivier Fogel; Mathilde Tissier; Chahrazad Cherifi; Karim Ibrahim; Chayma Saadan; Camille Flageollet; Wilton Albeiro Gomez Henao; Judith Melki; Robert Olaso; Jean-François Deleuze; Brigitte Baroukh; Catherine Chaussain; Lars Rogge; Elisabetta Bianchi; Marcio Do Cruzeiro; Frederique M F Cornelis; Rik Lories; Patricia Albanese; Xavier Houard; Claire Bardet; Corinne Miceli-RichardShow moreShow less
UMR-S 1333 Santé Orale, Institut National de la Santé et de la Recherche Médicale (INSERN), Université Paris Cité and Sorbonne Paris Nord, Montrouge, France; Department of Rheumatology, Hôpital Cochin, Assistance publique des Hôpitaux de Paris, Université Paris Cité, Paris, France; Immunoregulation Unit, Institut Pasteur, Université Paris Cité, Paris, France; Laboratory of Tissue Homeostasis and Disease, Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, Katholieke Universiteit (KU), Leuven, Belgium; Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), Université Paris-Est Créteil (UPEC), Créteil, France; Laboratorio Internacional Glycobiology, Cell Growth and Tissue Repair Research Unit Universidad Nacional Autonoma de México (Gly-CRRETUNAM), Departamento de Bioquímica, Universidad Nacional Autónoma de México, Ciudad de México, México; Laboratory Diseases and Hormones of the Nervous Systems, Inserm U1195, Université Paris-Saclay, Le Kremlin Bicêtre, France; Commissariat à l'Energie Atomique et aux energies alternatives (CEA), Centre National de Recherche en Génomique Humaine (CNRGH), Université Paris-Saclay, Évry, France; Plateforme de Développement des Anticorps (PDA) et MouseT’IC, Institut Cochin, Université Paris Cité, Paris, France; Division of Rheumatology, University Hospitals Leuven, Leuven, Belgium; Centre de Recherche Saint-Antoine, CRSA, INSERM, Sorbonne Université, Paris, FranceShow moreShow less
Single-cell analysis identifies monocyte signatures of disease activity and clinical subtypes in Behçet’s disease
Elio Carmona; Rabia Deniz; Cemal Bes; Haner Direskeneli; Ahmet Gül; Amr H. SawalhaShow moreShow less
Division of Pediatric Rheumatology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye; Division of Rheumatology, Department of Internal Medicine, Marmara University, Istanbul, Türkiye; Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye; Departments of Pediatrics, Medicine, and Immunology & Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAShow moreShow less
Functional insights into autoantibodies targeting muscarinic acetylcholine receptors in Sjögren’s disease
Fiona Engelke; Harald Heidecke; Kai Schulze-Forster; Heike Bähre; Yasmin Liß; Tina Hagedorn; Thomas Dörner; Diana Ernst; Jan Gras; Luca Quartuccio; Jacob Ritter; Benjamin Seeliger; Detlef Neumann; Torsten WitteShow moreShow less
Department of Rheumatology and Clinical Immunology, Hannover Medical School, Hannover, Germany; CellTrend GmbH, Luckenwalde, Germany; Institute of Pharmacology, Hannover Medical School, Hannover, Germany; Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Rheumatology Division, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, University of Udine, Udine, Italy; German Center for Lung Research (DZL), Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), Hannover, GermanyShow moreShow less
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis
Tommy K Annfeldt; Mina N Händel; Tobias Haugegaard; Marius Henriksen; Laura C Coates; Alexis Ogdie; William Tillett; Niti Goel; Dafna D Gladman; Ana-Maria Orbai; Maarten de Wit; Vibeke Strand; Philip J Mease; Oliver FitzGerald; Philip S Helliwell; Peter Tugwell; Ying-Ying Leung; Robin ChristensenShow moreShow less
Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Research Unit OPEN at Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Medicine/Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, UK; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Patient Research Partner and Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Psoriatic Arthritis Program, Johns Hopkins Arthritis Center, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; GRAPPA Patient Research Partner, The Netherlands; Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, USA; Swedish Medical Center/Providence St. Joseph Health, Seattle, WA, USA; University of Washington School of Medicine, Seattle, WA, USA; UCD Conway Institute, School of Medicine, University College Dublin, Belfield, Dublin, Ireland.; LIRMM, University of Leeds, Leeds, UK; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Singapore General Hospital, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Cochrane Denmark & Centre for Evidence-Based Medicine Odense (CEBMO), Department of Clinical Research, University of Southern Denmark, DenmarkShow moreShow less
Single-cell multiomics reveals activation of the STAT3–PIM1 axis in T-cell subsets in proteinase 3-ANCA–positive granulomatosis with polyangiitis
Nanthicha Inrueangsri; Carlo G. Bonasia; Kevin P. Mennega; Matthew A. Jackson-Wood; Samuel J. Bullers; Oliver Wood; Malte Borggrewe; Petya D. Marinova; Rindert R. Venema; Theo Bijma; Rosanne D. Reitsema; Wayel H. Abdulahad; Jan-Stephan F. Sanders; Abraham Rutgers; Peter HeeringaShow moreShow less
Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Gilead Sciences, Oxford, United Kingdom; Independent Bioinformatics Consultant, Hamburg, Germany; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsShow moreShow less
FAQ
How long does ANNALS OF THE RHEUMATIC DISEASES take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for ANNALS OF THE RHEUMATIC DISEASES. The fastest paper went from submission to acceptance in 69 days (Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis, received 2026-01-21, accepted 2026-03-31); the slowest took 317 days. The average is 162.4 days and the median is 134.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
